United Therapeutics Corporation (UTHR) — Defensive Interval Ratio
United Therapeutics Corporation (UTHR) has a Defensive Interval Ratio of 1289 days as of September 2025. Defensive assets of $1.93 Billion (cash $-, short-term investments $1.63 Billion, receivables $297.70 Million) cover 1289 days of daily cash needs of $1.50 Million/day. See UTHR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
United Therapeutics Corporation Defensive Interval Ratio (1998–2024)
This chart shows how United Therapeutics Corporation's Defensive Interval Ratio has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the ratio stands at 1289 days, meaning defensive assets of $1.93 Billion can fund 1289 days of operations without new revenue. See United Therapeutics Corporation (UTHR) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for United Therapeutics Corporation (1998–2024)
The table below presents the year-by-year Defensive Interval Ratio for United Therapeutics Corporation from 1998 to 2024, covering 27 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is United Therapeutics Corporation worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 914 days | $1.85 Billion | $2.02 Million/day | $- | $1.57 Billion | ▼ -23 days |
| 2023 | 937 days | $2.07 Billion | $2.20 Million/day | $- | $1.79 Billion | ▼ -1294 days |
| 2022 | 2231 days | $2.10 Billion | $940.27K/day | $- | $1.88 Billion | ▲ +756 days |
| 2021 | 1476 days | $1.23 Billion | $836.71K/day | $- | $1.04 Billion | ▲ +60 days |
| 2020 | 1415 days | $1.25 Billion | $885.75K/day | $- | $1.10 Billion | ▲ +707 days |
| 2019 | 709 days | $898.90 Million | $1.27 Million/day | $- | $747.50 Million | ▼ -509 days |
| 2018 | 1217 days | $922.40 Million | $757.81K/day | $- | $746.70 Million | ▲ +791 days |
| 2017 | 426 days | $519.40 Million | $1.22 Million/day | $- | $222.30 Million | ▲ +160 days |
| 2016 | 266 days | $242.30 Million | $910.96K/day | $- | $27.80 Million | ▲ +5 days |
| 2015 | 261 days | $314.83 Million | $1.21 Million/day | $- | $122.00 Million | ▼ -72 days |
| 2014 | 333 days | $460.13 Million | $1.38 Million/day | $- | $297.84 Million | ▲ +49 days |
| 2013 | 284 days | $535.94 Million | $1.88 Million/day | $- | $409.64 Million | ▼ -628 days |
| 2012 | 912 days | $441.80 Million | $484.26K/day | $- | $325.18 Million | ▲ +347 days |
| 2011 | 566 days | $329.48 Million | $582.40K/day | $- | $240.80 Million | ▲ +184 days |
| 2010 | 382 days | $448.63 Million | $1.17 Million/day | $- | $374.92 Million | ▲ +180 days |
| 2009 | 202 days | $182.40 Million | $904.62K/day | $- | $129.14 Million | ▼ -664 days |
| 2008 | 866 days | $137.20 Million | $158.43K/day | $- | $106.60 Million | ▲ +625 days |
| 2007 | 241 days | $180.39 Million | $747.29K/day | $- | $150.73 Million | ▼ -2836 days |
| 2006 | 3078 days | $162.33 Million | $52.74K/day | $- | $136.68 Million | ▲ +1186 days |
| 2005 | 1892 days | $75.29 Million | $39.79K/day | $- | $56.30 Million | ▲ +1471 days |
| 2004 | 421 days | $16.01 Million | $37.98K/day | $- | $200.00K | ▲ +57 days |
| 2003 | 365 days | $10.61 Million | $29.09K/day | $- | $- | ▼ -1256 days |
| 2002 | 1621 days | $41.34 Million | $25.50K/day | $- | $31.68 Million | ▲ +408 days |
| 2001 | 1214 days | $35.90 Million | $29.58K/day | $- | $31.68 Million | ▲ +679 days |
| 2000 | 535 days | $16.83 Million | $31.49K/day | $- | $14.48 Million | ▼ -2139 days |
| 1999 | 2674 days | $33.70 Million | $12.60K/day | $- | $33.30 Million | ▲ +2654 days |
| 1998 | 20 days | $100.00K | $4.93K/day | $- | $- | — |